World Of Taxonomy
C204833Level 6

R-DHAC Followed by R-CHOP Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of dexamethasone, high-dose cytarabine (Ara-C), carboplatin and rituximab (R-DHAC), followed by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP), that can be used in the treatment of mantle cell lymphoma.

**Synonyms:** - Carboplatin/Cytarabine/Dexamethasone/Rituximab Followed by Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine - R-DHAC Followed by R-CHOP - Rituximab/Dexamethasone/High-dose Ara-C/Carboplatin Followed by Rituximab/Cyclophosphamide/Doxorubicin/Vincristine/Prednisone - Rituximab/Dexamethasone/High-dose Cytarabine/Carboplatin Followed by Rituximab/Cyclophosphamide/Doxorubicin/Vincristine/Prednisone

GET/api/v1/systems/nci_thesaurus/nodes/C204833
Official DownloadCC BY 4.0Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.